AIPLA Direct, LIVE
Free for Members: AIPLA Direct Live - Buyer Beware: DOCX Filing is Coming to a Computer Near You!
May 22, 2020 12:30 PM to 1:30 PM
Member-benefit exclusive!
No CLE credit available.
Friday, May 22nd at 12:30 pm EDT
Electronically filing a patent application with the USPTO is about to change. Many applicants currently electronically file a PDF of a patent application that the inventors have reviewed. Once reviewed, the application should not be changed before filling, right? In the near future, you will need to file applications via the “Patent Center” in a DOCX format, or pay a $400 fee on top of the filing fees. Did the inventors review the DOCX version of the application? Do you need to change your internal drafting and review processes? Are you using application drafting tools that result in a DOCX version that will not be changed upon submitting it to the USPTO?
We will provide some important tips to enable you to safely file applications in DOCX format without risking your license to practice law or having your insurance company freak out.
Presented by:
Brad Forrest, Schwegman Lundberg & Woessner, P.A.
Kasie Grover, Schwegman Lundberg & Woessner, P.A
Add to:
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.